J. Jurado

发表

Isolated use of vibration perception thresholds and semmes-weinstein monofilament in diagnosing diabetic polyneuropathy: "the North Catalonia diabetes study".

J. Pou, J. Ybarra, J. Jurado, 2007, The Nursing clinics of North America.

Primary hyperparathyroidism, insulin resistance, and cardiovascular disease: a review.

J. Pou, J. Ybarra, T. Doñate, 2007, The Nursing clinics of North America.

Research update for articles published in EJCI in 2009

J. Sztajzel, A. Wykrętowicz, C. Buechler, 2011 .

GSK-3β, a pivotal kinase in Alzheimer disease

J. Ávila, F. Hernández, J. Jurado, 2014, Front. Mol. Neurosci..

Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study

J. Pou, J. H. Romeo, P. Solanas, 2009, Journal of the American Academy of Nurse Practitioners.

Association between sleep-disordered breathing, aminoterminal pro-brain natriuretic peptide (NT-proBNP) levels and insulin resistance in morbidly obese young women.

S. Pujadas, F. Planas, J. Pou, 2009, European journal of internal medicine.

Clinical screening and diagnosis of diabetic polyneuropathy: the North Catalonia Diabetes Study

J. H. Romeo, J. Ybarra, J. Jurado, 2009, European journal of clinical investigation.

Transforming growth factor beta 1 as a biomarker of diabetic peripheral neuropathy: cross-sectional study.

J. H. Romeo, J. Ybarra, J. Jurado, 2010, Journal of diabetes and its complications.

Anthropometrical measures are easily obtainable sensitive and specific predictors of insulin resistance in healthy individuals

J. Ordóñez‐Llanos, A. Leiva, J. Pou, 2005 .

Amino-Terminal Brain Natriuretic Peptide is Related to the Presence of Diabetic Polyneuropathy Independently of Cardiovascular Disease

J. Pou, J. Ybarra, J. Jurado, 2007, Diabetes Care.

Angiotensin-converting enzyme gene single polymorphism as a genetic biomarker of diabetic peripheral neuropathy: longitudinal prospective study.

J. H. Romeo, J. Ybarra, E. Zabaleta-del-Olmo, 2012, Journal of diabetes and its complications.

Angiotensin Converting Enzyme Gene Polymorphism as a Genetic Biomarker of Diabetic Peripheral Neuropathy: Longitudinal Prospective Study

J. H. Romeo, J. Ybarra, E. Zabaleta-del-Olmo, 2012 .

[Selection of risk and diagnosis in diabetic polyneuropathy. Validation of method of new systems].

J. Jurado, Jacinto Caula, Josep Maria Pou i Torelló, 2006, Atencion primaria.

Transforming growth factor beta 1 as a biomarker of diabetic peripheral neuropathy: cross-sectional study.

J. H. Romeo, J. Ybarra, J. Jurado, 2010, Journal of diabetes and its complications.

The impact of previous diabetes education level on the control of cardiovascular risk factors in type 2 diabetic patients at the start of the North Catalonia Diabetes Study

J. Jurado, M. Pou, J. Jurado, 2006 .